Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT

Por Valent, Peter, Cerny-Reiterer, Sabine, Hoermann, Gregor, Sperr, Wolfgang R, Müllauer, Leonhard, Mannhalter, Christine, Pehamberger, Hubert
Publicado no Am J Blood Res (2014)

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells

Por Bauer, K., Hadzijusufovic, E., Cerny-Reiterer, S., Hoermann, G., Reifinger, M., Pirker, A., Valent, P., Willmann, M.
Publicado no Vet Comp Oncol (2016)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

Por Füreder, Wolfgang, Cerny-Reiterer, Sabine, Sperr, Wolfgang R., Müllauer, Leonhard, Jäger, Eva, Schwarzinger, Ilse, Geissler, Klaus, Valent, Peter
Publicado no Wien Klin Wochenschr (2016)

Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Por Schulenburg, Axel, Blatt, Katharina, Cerny-Reiterer, Sabine, Sadovnik, Irina, Herrmann, Harald, Marian, Brigitte, Grunt, Thomas W, Zielinski, Christoph C, Valent, Peter
Publicado no J Hematol Oncol (2015)

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

Por Bibi, Siham, Arslanhan, Melis Dilara, Langenfeld, Florent, Jeanningros, Sylvie, Cerny-Reiterer, Sabine, Hadzijusufovic, Emir, Tchertanov, Luba, Moriggl, Richard, Valent, Peter, Arock, Michel
Publicado em 2014

Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single ‘hit’ and cooperate in producing a mastocytosis-like disease in mice

Por Merz, Hartmut, Kaehler, Christian, Hoefig, Kai P., Branke, Biggi, Uckert, Wolfgang, Nadrowitz, Roger, Sabine-Cerny-Reiterer, Herrmann, Harald, Feller, Alfred C., Valent, Peter
Publicado em 2010

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia

Por Warsch, Wolfgang, Grundschober, Eva, Berger, Angelika, Gille, Lars, Cerny-Reiterer, Sabine, Tigan, Anca-Sarmiza, Hoelbl-Kovacic, Andrea, Valent, Peter, Moriggl, Richard, Sexl, Veronika
Publicado em 2012

NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation

Por Hadzijusufovic, E, Peter, B, Herrmann, H, Rülicke, T, Cerny-Reiterer, S, Schuch, K, Kenner, L, Thaiwong, T, Yuzbasiyan-Gurkan, V, Pickl, W F, Willmann, M, Valent, P
Publicado em 2012

Identification of Basophils as a Major Source of Hepatocyte Growth Factor in Chronic Myeloid Leukemia: A Novel Mechanism of BCR-ABL1-Independent Disease Progression

Por Cerny-Reiterer, Sabine, Ghanim, Viviane, Hoermann, Gregor, Aichberger, Karl J, Herrmann, Harald, Muellauer, Leonhard, Repa, Andreas, Sillaber, Christian, Walls, Andrew F, Mayerhofer, Matthias, Valent, Peter
Publicado em 2012

Overexpression of primary microRNA 221/222 in acute myeloid leukemia

Por Rommer, Anna, Steinleitner, Katarina, Hackl, Hubert, Schneckenleithner, Christine, Engelmann, Maria, Scheideler, Marcel, Vlatkovic, Irena, Kralovics, Robert, Cerny-Reiterer, Sabine, Valent, Peter, Sill, Heinz, Wieser, Rotraud
Publicado em 2013

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma

Por Keller, Alexandra, Wingelhofer, Bettina, Peter, Barbara, Bauer, Karin, Berger, Daniela, Gamperl, Susanne, Reifinger, Martin, Cerny-Reiterer, Sabine, Moriggl, Richard, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir
Publicado no Vet Comp Oncol (2017)

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

Por Valent, Peter, Berger, Jörg, Cerny-Reiterer, Sabine, Peter, Barbara, Eisenwort, Gregor, Hoermann, Gregor, Müllauer, Leonhard, Mannhalter, Christine, Steurer, Michael, Bettelheim, Peter, Horny, Hans-Peter, Arock, Michel
Publicado no Ann Hematol (2014)

Identification of Oncostatin M as a STAT5-Dependent Mediator of Bone Marrow Remodeling in KIT D816V-Positive Systemic Mastocytosis

Por Hoermann, Gregor, Cerny-Reiterer, Sabine, Perné, Andrea, Klauser, Miriam, Hoetzenecker, Konrad, Klein, Katharina, Müllauer, Leonhard, Gröger, Marion, Nijman, Sebastian M.B., Klepetko, Walter, Valent, Peter, Mayerhofer, Matthias
Publicado em 2011

Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis : Subcellular Distribution and Role of the Transforming Oncoprotein KIT D816V

Por Baumgartner, Christian, Cerny-Reiterer, Sabine, Sonneck, Karoline, Mayerhofer, Matthias, Gleixner, Karoline V., Fritz, Richard, Kerenyi, Marc, Boudot, Cedric, Gouilleux, Fabrice, Kornfeld, Jan-Wilhelm, Sillaber, Christian, Moriggl, Richard, Valent, Peter
Publicado em 2009

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H()

Por Valent, Peter, Blatt, Katharina, Eisenwort, Gregor, Herrmann, Harald, Cerny-Reiterer, Sabine, Thalhammer, Renate, Müllauer, Leonhard, Hoermann, Gregor, Sadovnik, Irina, Schwarzinger, Ilse, Sperr, Wolfgang R., Mannhalter, Christine, Horny, Hans-Peter
Publicado em 2013

CD34(+)/CD38(−) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

Por Herrmann, Harald, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Blatt, Katharina, Herndlhofer, Susanne, Rabitsch, Werner, Jäger, Eva, Mitterbauer-Hohendanner, Gerlinde, Streubel, Berthold, Selzer, Edgar, Schwarzinger, Ilse, Sperr, Wolfgang R., Valent, Peter
Publicado em 2012

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)

Por Herrmann, Harald, Blatt, Katharina, Shi, Junwei, Gleixner, Karoline V., Cerny-Reiterer, Sabine, Müllauer, Leonhard, Vakoc, Christopher R., Sperr, Wolfgang R., Horny, Hans-Peter, Bradner, James E., Zuber, Johannes, Valent, Peter
Publicado em 2012

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their acti...

Por Cuapio, Angélica, Post, Mirte, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Stefanzl, Gabriele, Basilio, Jose, Herndlhofer, Susanne, Sperr, Wolfgang R., Brons, Nicolaas H.C., Casanova, Emilio, Zimmer, Jacques, Valent, Peter, Hofer, Erhard
Publicado no Oncotarget (2016)

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

Por Heller, G, Topakian, T, Altenberger, C, Cerny-Reiterer, S, Herndlhofer, S, Ziegler, B, Datlinger, P, Byrgazov, K, Bock, C, Mannhalter, C, Hörmann, G, Sperr, W R, Lion, T, Zielinski, C C, Valent, P, Zöchbauer-Müller, S
Publicado no Leukemia (2016)

Targeting of VEGF‐dependent transendothelial migration of cancer cells by bevacizumab

Por Prager, Gerald W., Lackner, Eva-Maria, Krauth, Maria-Theresa, Unseld, Matthias, Poettler, Marina, Laffer, Sylvia, Cerny-Reiterer, Sabine, Lamm, Wolfgang, Kornek, Gabriela V., Binder, Bernd R., Zielinski, Christoph C., Valent, Peter
Publicado no Mol Oncol (2010)